Oxford Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-35,547
| Closed | -$169K | – | 2106 |
|
|
2019
Q2 | $169K | Sell |
35,547
-52,953
| -60% | -$252K | ﹤0.01% | 1573 |
|
|
2019
Q1 | $484K | Sell |
88,500
-16,089
| -15% | -$88K | 0.01% | 1226 |
|
|
2018
Q4 | $318K | Buy |
104,589
+59,588
| +132% | +$181K | 0.01% | 1376 |
|
|
2018
Q3 | $185K | Sell |
45,001
-29,136
| -39% | -$120K | ﹤0.01% | 1610 |
|
|
2018
Q2 | $287K | Buy |
74,137
+14,596
| +25% | +$56.5K | 0.01% | 1506 |
|
|
2018
Q1 | $377K | Buy |
+59,541
| New | +$377K | 0.01% | 1336 |
|
|
2016
Q1 | – | Sell |
-5,379
| Closed | -$342K | – | 990 |
|
|
2015
Q4 | $342K | Buy |
+5,379
| New | +$342K | 0.01% | 738 |
|